Inventor · disambiguated record
Elodie Belnoue
Also filed as: BELNOUE ELODIE · BELNOUE ELODIE ANNE FRANÇOISE
7 granted patents·9 pending applications·14 citations·filing 2014–2025
78Inventor score
Top patents by PatentIndex Score
16 records- 0193US11338027B2Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist for treatment of cancerAMAL THERAPEUTICS SA·Filed 2020·Granted May 24, 2022·5 cites·44 claims
- 0283US9809801B2Anti-mycobacterial vaccinesUNIV GENEVE·Filed 2014·Granted Nov 7, 2017·9 cites·3 claims
- 0377US12453762B2Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for treatment of glioblastomaAMAL THERAPEUTICS SA·Filed 2021·Granted Oct 28, 2025·0 cites·26 claims
- 0476US12220450B2Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for treatment of colorectal cancerAMAL THERAPEUTICS SA·Filed 2021·Granted Feb 11, 2025·0 cites·26 claims
- 0576US12178788B2Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonistAMAL THERAPEUTICS SA·Filed 2021·Granted Dec 31, 2024·0 cites·38 claims
- 0673US12220387B2Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist for treatment of cancerAMAL THERAPEUTICS SA·Filed 2022·Granted Feb 11, 2025·0 cites·21 claims
- 0771US12214048B2Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for use in medicineAMAL THERAPEUTICS SA·Filed 2022·Granted Feb 4, 2025·0 cites·32 claims
- 0867US2025312428A1Heterologous Prime Boost VaccineBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 0964US2022088162A1Heterologous Prime Boost VaccineBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1062US2018133339A1A Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist For Treatment Of GlioblastomaAMAL THERAPEUTICS SA·Filed 2016·Application pending·0 cites
- 1159US2024033336A1Tumor antigens, compounds comprising the tumor antigens and uses thereofBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1259US2019255165A1Fusion Comprising A Cell Penetrating Peptide, A Multi Epitope And A TLR Peptide Agonist For Treatment Of CancerAMAL THERAPEUTICS SA·Filed 2017·Application pending·0 cites
- 1358US2018133295A1A Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide AgonistAMAL THERAPEUTICS SA·Filed 2016·Application pending·0 cites
- 1458US2018133338A1A Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist For Treatment Of Colorectal CancerAMAL THERAPEUTICS SA·Filed 2016·Application pending·0 cites
- 1555US2022111028A1Combination Of A STING Agonist And A Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide AgonistBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1649US2019175748A1Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist for use in medicineAMAL THERAPEUTICS SA·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →